https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.6_suppl.221

Prior therapy and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC) in a hospital-based database / Francini, E; Gray, KP; Xie, WL; Kantoff, PW; Harshman, LC; Taplin, ME. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - STAMPA. - 35:(2017), pp. 221-221. [10.1200/JCO.2017.35.6_suppl.221]

Prior therapy and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC) in a hospital-based database

Francini, E
Writing – Original Draft Preparation
;
2017

Abstract

https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.6_suppl.221
2017
Francini, E; Gray, KP; Xie, WL; Kantoff, PW; Harshman, LC; Taplin, ME
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1341851
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact